T. Rowe Price Associates’s Pulmonx LUNG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $44K | Hold |
|
|||||
|
2025
Q3 | $33K | Sell |
|
|||||
|
2025
Q2 | $98K | Buy |
|
|||||
|
2025
Q1 | $244K | Buy |
|
|||||
|
2024
Q4 | $229K | Sell |
|
|||||
|
2024
Q3 | $357K | Buy |
|
|||||
|
2024
Q2 | $271K | Buy |
|
|||||
|
2024
Q1 | $332K | Buy |
|
|||||
|
2023
Q4 | $435K | Buy |
|
|||||
|
2023
Q3 | $347K | Buy |
|
|||||
|
2023
Q2 | $391K | Buy |
|
|||||
|
2023
Q1 | $300K | Buy |
|
|||||
|
2022
Q4 | $220K | Buy |
|
|||||
|
2022
Q3 | $424K | Buy |
|
|||||
|
2022
Q2 | $344K | Buy |
|
|||||
|
2022
Q1 | $521K | Sell |
|
|||||
|
2021
Q4 | $679K | Sell |
|
|||||
|
2021
Q3 | $14.8M | Buy |
|
|||||
|
2021
Q2 | $17.2M | Sell |
|
|||||
|
2021
Q1 | $32.8M | Buy |
|
|||||
|
2020
Q4 | $25.5M | Buy |
|